NRX Pharmaceuticals, Inc.
corporate_fare Company Profile
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 43 items for NRXP at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Shareholders to Vote on Significant Increase in Equity Incentive Plan Share Reserve
- NRX Pharmaceuticals Appoints Joseph M. Casper as Chief Operating Officer
- NRX Pharmaceuticals Receives Nasdaq Non-Compliance Notice for Delayed Annual Meeting
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.23M
Net Income
-$28.62M
Op. Cash Flow
-$14.11M
Gross Profit
$720K
Operating Income
-$16.22M
Cash & Equivalents
$7.8M
Debt / Equity
0.00×
Net Margin
-23.36×
Shares Outstanding
31.73M sh
Source: 10-K · filed 2026-03-23 · accession 0001437749-26-009418
show_chartPrice Chart
Loading chart...
feed NRXP - Filings & News (Page 3)
NRXP
Feb 13, 2026, 4:31 PM EST
Price at Filing:
$1.83
Real-time Price:
$2.23
Change:
+$0.3993 (+22%)
Market Cap:
$95.305M
NRXP
Feb 02, 2026, 5:16 PM EST
Price at Filing:
$2.12
Real-time Price:
$2.23
Change:
+$0.1093 (+5%)
Market Cap:
$95.305M
NRXP
Jan 16, 2026, 5:09 PM EST
Price at Filing:
$2.24
Real-time Price:
$2.23
Change:
-$0.0107 (-0.48%)
Market Cap:
$95.305M